Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients with Advanced ALK-Positive NSCLC with or Without Baseline Central Nervous System Metastases
JTO CLINICAL AND RESEARCH REPORTS(2023)
Key words
Alectinib,Crizotinib,Real-world data,ALEX,Non–small cell lung cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined